- Home
- CLDI vs CVR Comparison
CLDI vs CVR Comparison
Compare CLDI & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- CVR
- Stock Information
- Founded
- CLDI 2014
- CVR 1920
- Country
- CLDI United States
- CVR United States
- Employees
- CLDI N/A
- CVR N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- CVR Industrial Machinery/Components
- Sector
- CLDI Health Care
- CVR Industrials
- Exchange
- CLDI Nasdaq
- CVR Nasdaq
- Market Cap
- CLDI 14.0M
- CVR 14.9M
- IPO Year
- CLDI N/A
- CVR N/A
- Fundamental
- Price
- CLDI $0.48
- CVR $9.30
- Analyst Decision
- CLDI Strong Buy
- CVR
- Analyst Count
- CLDI 2
- CVR 0
- Target Price
- CLDI $15.00
- CVR N/A
- AVG Volume (30 Days)
- CLDI 386.9K
- CVR 5.6K
- Earning Date
- CLDI 05-13-2025
- CVR 05-09-2025
- Dividend Yield
- CLDI N/A
- CVR 1.29%
- EPS Growth
- CLDI N/A
- CVR N/A
- EPS
- CLDI N/A
- CVR N/A
- Revenue
- CLDI N/A
- CVR $26,986,627.00
- Revenue This Year
- CLDI N/A
- CVR N/A
- Revenue Next Year
- CLDI N/A
- CVR N/A
- P/E Ratio
- CLDI N/A
- CVR N/A
- Revenue Growth
- CLDI N/A
- CVR N/A
- 52 Week Low
- CLDI $0.35
- CVR $8.25
- 52 Week High
- CLDI $4.90
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- CLDI 38.44
- CVR 36.55
- Support Level
- CLDI $0.41
- CVR $8.25
- Resistance Level
- CLDI $0.45
- CVR $9.49
- Average True Range (ATR)
- CLDI 0.07
- CVR 0.56
- MACD
- CLDI 0.02
- CVR 0.00
- Stochastic Oscillator
- CLDI 56.57
- CVR 41.18
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.